cisplatin teva
teva pharma b.v. - cisplatin - concentrate for soln for inf - 0.5 mg/ml
cisplatin ebewe
sandoz pty ltd - cisplatin -
cisplatin ebewe
novartis new zealand ltd - cisplatin 1 mg/ml - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml excipient: hydrochloric acid sodium chloride water for injection - cisplatin ebewe is indicated as palliative therapy to be employed as follows: metastatic non-seminomatous germ cell carcinoma: in established combination therapy with other approved chemotherapeutic agents in patients with metastatic non-seminomatous germ cell tumours who have already received appropriate surgical and/or radiotherapeutic procedures. metastatic ovarian tumours: cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumours refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy. advanced and refractory carcinoma of the bladder: cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with advanced stage bladder cancer refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy. squamous cell carcinoma of the head and neck (refractory to standard chemotherapy): cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with squamous cell carcinoma of the head and neck refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy.
abiplatin teva
abic marketing ltd, israel - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - cisplatin - cisplatin - palliative therapy to be employed either alone, or more commonly in established combination therapy with orher approved chemotherapeutic agents and in patients with metastatic testicular tumor and metastatic ovarian tumor who have alreasy received appropriate surgical and/or radiotherapeutic procedures and in patients with advanced bladder cancer.
cisplatin strides 1 mg/ml concentrate for soln for inf
strides arcolab international limited - cisplatin - concentrate for soln for inf - 1 mg/ml
cisplatin teva 0.5 mg/ml concentrate for soln for inf
teva pharma b.v. - cisplatin - concentrate for soln for inf - 0.5 mg/ml
co-tipol max 1000mg/60mg suppositories
carysfort healthcare limited - codeine phosphate hemihydrate; paracetamol - suppository - 1000 mg/60 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol
co-tipol 500mg/30mg hard capsules
carysfort healthcare limited - paracetamol; codeine phosphate hemihydrate - capsule, hard - 500 mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol
co-tipol 500mg/30mg suppositories
carysfort healthcare limited - codeine phosphate hemihydrate; paracetamol - suppository - 500 mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol
claritin allergy + sinus tablet (immediate and extended release)
bayer inc - pseudoephedrine sulfate; loratadine - tablet (immediate and extended release) - 120mg; 5mg - pseudoephedrine sulfate 120mg; loratadine 5mg - second generation antihistamines